Standard
Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. / Perner, Anders; Haase, Nicolai; Guttormsen, Anne B; Tenhunen, Jyrki; Klemenzson, Gudmundur; Åneman, Anders; Madsen, Kristian R; Møller, Morten H; Elkjær, Jeanie M; Poulsen, Lone M; Bendtsen, Asger; Winding, Robert; Steensen, Morten; Berezowicz, Pawel; Søe-Jensen, Peter; Bestle, Morten; Strand, Kristian; Wiis, Jørgen; White, Jonathan O; Thornberg, Klaus J; Quist, Lars; Nielsen, Jonas; Andersen, Lasse H; Holst, Lars B; Thormar, Katrin; Kjældgaard, Anne-Lene; Fabritius, Maria L; Mondrup, Frederik; Pott, Frank C; Møller, Thea P; Winkel, Per; Wetterslev, Jørn; 6S Trial Group.
In:
New England Journal of Medicine, Vol. 367, No. 2, 2012, p. 124-34.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Perner, A, Haase, N, Guttormsen, AB, Tenhunen, J, Klemenzson, G, Åneman, A, Madsen, KR, Møller, MH, Elkjær, JM, Poulsen, LM, Bendtsen, A, Winding, R, Steensen, M, Berezowicz, P, Søe-Jensen, P, Bestle, M, Strand, K, Wiis, J, White, JO, Thornberg, KJ, Quist, L, Nielsen, J, Andersen, LH, Holst, LB, Thormar, K, Kjældgaard, A-L, Fabritius, ML, Mondrup, F
, Pott, FC, Møller, TP, Winkel, P, Wetterslev, J & 6S Trial Group 2012, '
Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis',
New England Journal of Medicine, vol. 367, no. 2, pp. 124-34.
https://doi.org/10.1056/NEJMoa1204242
APA
Perner, A., Haase, N., Guttormsen, A. B., Tenhunen, J., Klemenzson, G., Åneman, A., Madsen, K. R., Møller, M. H., Elkjær, J. M., Poulsen, L. M., Bendtsen, A., Winding, R., Steensen, M., Berezowicz, P., Søe-Jensen, P., Bestle, M., Strand, K., Wiis, J., White, J. O., ... 6S Trial Group (2012).
Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis.
New England Journal of Medicine,
367(2), 124-34.
https://doi.org/10.1056/NEJMoa1204242
Vancouver
Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A et al.
Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis.
New England Journal of Medicine. 2012;367(2):124-34.
https://doi.org/10.1056/NEJMoa1204242
Author
Perner, Anders ; Haase, Nicolai ; Guttormsen, Anne B ; Tenhunen, Jyrki ; Klemenzson, Gudmundur ; Åneman, Anders ; Madsen, Kristian R ; Møller, Morten H ; Elkjær, Jeanie M ; Poulsen, Lone M ; Bendtsen, Asger ; Winding, Robert ; Steensen, Morten ; Berezowicz, Pawel ; Søe-Jensen, Peter ; Bestle, Morten ; Strand, Kristian ; Wiis, Jørgen ; White, Jonathan O ; Thornberg, Klaus J ; Quist, Lars ; Nielsen, Jonas ; Andersen, Lasse H ; Holst, Lars B ; Thormar, Katrin ; Kjældgaard, Anne-Lene ; Fabritius, Maria L ; Mondrup, Frederik ; Pott, Frank C ; Møller, Thea P ; Winkel, Per ; Wetterslev, Jørn ; 6S Trial Group. / Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. In: New England Journal of Medicine. 2012 ; Vol. 367, No. 2. pp. 124-34.
Bibtex
@article{a78d029dceaf45c2999e9b996a9d71fa,
title = "Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis",
abstract = "Hydroxyethyl starch (HES) [corrected] is widely used for fluid resuscitation in intensive care units (ICUs), but its safety and efficacy have not been established in patients with severe sepsis.",
author = "Anders Perner and Nicolai Haase and Guttormsen, {Anne B} and Jyrki Tenhunen and Gudmundur Klemenzson and Anders {\AA}neman and Madsen, {Kristian R} and M{\o}ller, {Morten H} and Elkj{\ae}r, {Jeanie M} and Poulsen, {Lone M} and Asger Bendtsen and Robert Winding and Morten Steensen and Pawel Berezowicz and Peter S{\o}e-Jensen and Morten Bestle and Kristian Strand and J{\o}rgen Wiis and White, {Jonathan O} and Thornberg, {Klaus J} and Lars Quist and Jonas Nielsen and Andersen, {Lasse H} and Holst, {Lars B} and Katrin Thormar and Anne-Lene Kj{\ae}ldgaard and Fabritius, {Maria L} and Frederik Mondrup and Pott, {Frank C} and M{\o}ller, {Thea P} and Per Winkel and J{\o}rn Wetterslev and Pott, {Frank Christian}",
year = "2012",
doi = "10.1056/NEJMoa1204242",
language = "English",
volume = "367",
pages = "124--34",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachusetts Medical Society",
number = "2",
}
RIS
TY - JOUR
T1 - Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis
AU - Perner, Anders
AU - Haase, Nicolai
AU - Guttormsen, Anne B
AU - Tenhunen, Jyrki
AU - Klemenzson, Gudmundur
AU - Åneman, Anders
AU - Madsen, Kristian R
AU - Møller, Morten H
AU - Elkjær, Jeanie M
AU - Poulsen, Lone M
AU - Bendtsen, Asger
AU - Winding, Robert
AU - Steensen, Morten
AU - Berezowicz, Pawel
AU - Søe-Jensen, Peter
AU - Bestle, Morten
AU - Strand, Kristian
AU - Wiis, Jørgen
AU - White, Jonathan O
AU - Thornberg, Klaus J
AU - Quist, Lars
AU - Nielsen, Jonas
AU - Andersen, Lasse H
AU - Holst, Lars B
AU - Thormar, Katrin
AU - Kjældgaard, Anne-Lene
AU - Fabritius, Maria L
AU - Mondrup, Frederik
AU - Pott, Frank C
AU - Møller, Thea P
AU - Winkel, Per
AU - Wetterslev, Jørn
AU - 6S Trial Group
PY - 2012
Y1 - 2012
N2 - Hydroxyethyl starch (HES) [corrected] is widely used for fluid resuscitation in intensive care units (ICUs), but its safety and efficacy have not been established in patients with severe sepsis.
AB - Hydroxyethyl starch (HES) [corrected] is widely used for fluid resuscitation in intensive care units (ICUs), but its safety and efficacy have not been established in patients with severe sepsis.
U2 - 10.1056/NEJMoa1204242
DO - 10.1056/NEJMoa1204242
M3 - Journal article
C2 - 22738085
VL - 367
SP - 124
EP - 134
JO - New England Journal of Medicine
JF - New England Journal of Medicine
SN - 0028-4793
IS - 2
ER -
